136 related articles for article (PubMed ID: 6600790)
1. Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.
Pessayre D; Tinel M; Larrey D; Cobert B; Funck-Brentano C; Babany G
J Pharmacol Exp Ther; 1983 Mar; 224(3):685-91. PubMed ID: 6600790
[TBL] [Abstract][Full Text] [Related]
2. Self-induction by oleandomycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Comparison with troleandomycin.
Pessayre D; Descatoire V; Tinel M; Larrey D
J Pharmacol Exp Ther; 1982 Apr; 221(1):215-21. PubMed ID: 6977641
[No Abstract] [Full Text] [Related]
3. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
[TBL] [Abstract][Full Text] [Related]
4. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Tinel M; Descatoire V; Larrey D; Loeper J; Labbe G; Letteron P; Pessayre D
J Pharmacol Exp Ther; 1989 Aug; 250(2):746-51. PubMed ID: 2527301
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
Pershing LK; Franklin MR
Xenobiotica; 1982 Nov; 12(11):687-99. PubMed ID: 6984805
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for isaxonine hepatitis. II. Protective role of glutathione and toxicological studies in mice.
Fouin-Fortunet H; Lettéron P; Tinel M; Degott C; Flejou JF; Pessayre D
J Pharmacol Exp Ther; 1984 Jun; 229(3):851-8. PubMed ID: 6547180
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
Delaforge M; Sartori E; Mansuy D
Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
[TBL] [Abstract][Full Text] [Related]
8. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
[TBL] [Abstract][Full Text] [Related]
9. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
Danan G; Descatoire V; Pessayre D
J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
[TBL] [Abstract][Full Text] [Related]
11. Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
Delaforge M; Jaouen M; Mansuy D
Biochem Pharmacol; 1983 Aug; 32(15):2309-18. PubMed ID: 6603844
[TBL] [Abstract][Full Text] [Related]
12. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.
Larrey D; Tinel M; Pessayre D
Biochem Pharmacol; 1983 May; 32(9):1487-93. PubMed ID: 6860368
[TBL] [Abstract][Full Text] [Related]
13. Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin.
Svensson CK; Drobitch RK; Kloss KA
J Pharm Sci; 1991 Mar; 80(3):225-8. PubMed ID: 2051337
[TBL] [Abstract][Full Text] [Related]
14. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
Werner M; Birner G; Dekant W
Drug Metab Dispos; 1995 Aug; 23(8):861-8. PubMed ID: 7493554
[TBL] [Abstract][Full Text] [Related]
15. Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans.
Pessayre D; Larrey D; Vitaux J; Breil P; Belghiti J; Benhamou JP
Biochem Pharmacol; 1982 May; 31(9):1699-704. PubMed ID: 6980648
[TBL] [Abstract][Full Text] [Related]
16. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
18. Biochemical background of toxic interaction between tiamulin and monensin.
Szucs G; Tamási V; Laczay P; Monostory K
Chem Biol Interact; 2004 Mar; 147(2):151-61. PubMed ID: 15013817
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytochrome P-450 in rat liver by the antibiotic troleandomycin: partial purificaton and properties of cytochrome P-450-troleandomycin metabolite complexes.
Mansuy D; Delaforge M; LeProvost E; Flinois JP; Columelli S; Beaune P
Biochem Biophys Res Commun; 1981 Dec; 103(4):1201-8. PubMed ID: 6977361
[No Abstract] [Full Text] [Related]
20. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
Sheffels P; Schroeder JL; Altuntas TG; Liggitt HD; Kharasch ED
Chem Res Toxicol; 2004 Sep; 17(9):1177-89. PubMed ID: 15377151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
